TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS WITH RECOMBINANT ERYTHROPOIETIN

被引：10

作者：

WINEARLS, CG ^{[1
]}

机构：

[1] ROYAL POSTGRAD MED SCH, DEPT MED, RENAL UNIT, LONDON W12 0HS, ENGLAND

来源：

NEPHRON | 1989年 / 51卷

关键词：

D O I：

10.1159/000185567

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：26 / 28

页数：3

共 16 条

[1]

BOMMER J, 1987, Nephrology Dialysis Transplantation, V2, P238

[2] BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS [J].

CASATI, S ;

PASSERINI, P ;

CAMPISE, MR ;

GRAZIANI, G ;

CESANA, B ;

PERISIC, M ;

PONTICELLI, C .

BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605) :1017-1020

[3] ERYTHROPOIETIN - THE DEVELOPING STORY [J].

COTES, PM .

BMJ-BRITISH MEDICAL JOURNAL, 1988, 296 (6625) :805-806

[4]

COTES PM, 1987, EXP HEMATOL, V15, P437

[5]

DESSYPRIS EN, 1987, BLOOD S, V70, pA132

[6] CHARACTERIZATION AND BIOLOGICAL EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN [J].

EGRIE, JC ;

STRICKLAND, TW ;

LANE, J ;

AOKI, K ;

COHEN, AM ;

SMALLING, R ;

TRAIL, G ;

LIN, FK ;

BROWNE, JK ;

HINES, DK .

IMMUNOBIOLOGY, 1986, 172 (3-5) :213-224

[7] ERYTHROPOIETIN COMING OF AGE [J].

ERSLEV, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :101-103

[8]

Eschbach J. W., 1987, BLOOD S, V70, p134a

[9] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].

ESCHBACH, JW ;

EGRIE, JC ;

DOWNING, MR ;

BROWNE, JK ;

ADAMSON, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78

[10]

REID CDL, 1988, IN PRESS BR J HAEMAT

← 1 2 →